Variant report

Variant	esv3443017
Chromosome Location	chr7:96634416-96636664
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:225)
CpG islands
(count:793)
Chromatin interactive
region (count:0)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:225 , 50 per page) page: 1 2 3 4 5

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr7:96635945-96636053	HepG2	liver:	n/a	n/a
2	ARID3A	chr7:96634618-96634978	HepG2	liver:	n/a	n/a
3	BACH1	chr7:96635933-96636250	H1-hESC	embryonic stem cell:	n/a	n/a
4	BHLHE40	chr7:96635542-96636136	HepG2	liver:	n/a	n/a
5	BRCA1	chr7:96635940-96636174	H1-hESC	embryonic stem cell:	n/a	n/a
6	CEBPB	chr7:96634678-96634979	HepG2	liver:	n/a	n/a
7	CEBPB	chr7:96636442-96636515	HepG2	liver:	n/a	n/a
8	CEBPB	chr7:96636013-96636180	H1-hESC	embryonic stem cell:	n/a	n/a
9	CEBPD	chr7:96635445-96636065	HepG2	liver:	n/a	n/a
10	CEBPD	chr7:96634587-96635060	HepG2	liver:	n/a	n/a
11	CHD1	chr7:96634537-96635203	H1-hESC	embryonic stem cell:	n/a	n/a
12	CHD1	chr7:96635579-96636197	H1-hESC	embryonic stem cell:	n/a	n/a
13	CHD2	chr7:96636030-96636087	H1-hESC	embryonic stem cell:	n/a	n/a
14	CHD2	chr7:96634395-96634980	H1-hESC	embryonic stem cell:	n/a	n/a
15	CHD2	chr7:96635208-96635347	HepG2	liver:	n/a	n/a
16	CHD2	chr7:96635210-96635393	H1-hESC	embryonic stem cell:	n/a	n/a
17	CHD2	chr7:96634580-96634945	HepG2	liver:	n/a	n/a
18	CHD2	chr7:96635671-96636183	HepG2	liver:	n/a	n/a
19	CREB1	chr7:96634629-96635010	ECC-1	luminal epithelium:	n/a	chr7:96634808-96634821
20	CREB1	chr7:96634637-96634937	A549	lung:	n/a	chr7:96634808-96634821
21	CREB1	chr7:96634423-96636395	HepG2	liver:	n/a	chr7:96634808-96634821
22	CREB1	chr7:96634508-96635040	A549	lung:	n/a	chr7:96634808-96634821
23	CREB1	chr7:96634508-96635111	ECC-1	luminal epithelium:	n/a	chr7:96634808-96634821
24	CREB1	chr7:96634482-96635078	H1-hESC	embryonic stem cell:	n/a	chr7:96634808-96634821
25	CREB1	chr7:96634525-96635063	H1-hESC	embryonic stem cell:	n/a	chr7:96634808-96634821
26	CREB1	chr7:96634620-96634986	GM12878	blood:	n/a	chr7:96634808-96634821
27	CREB1	chr7:96634511-96635155	HepG2	liver:	n/a	chr7:96634808-96634821
28	CTBP2	chr7:96635356-96637298	H1-hESC	embryonic stem cell:	n/a	n/a
29	CTBP2	chr7:96634493-96635057	H1-hESC	embryonic stem cell:	n/a	n/a
30	CTCF	chr7:96636280-96636430	GM12874	blood:	n/a	n/a
31	CTCF	chr7:96634700-96634850	GM12873	blood:	n/a	chr7:96634715-96634728
32	CTCF	chr7:96634540-96634690	BE2_C	brain:	n/a	n/a
33	CTCF	chr7:96635600-96635750	Caco-2	colon:	n/a	n/a
34	CTCF	chr7:96634700-96634850	AG09319	gingival:	n/a	chr7:96634715-96634728
35	CTCF	chr7:96634680-96634830	HepG2	liver:	n/a	chr7:96634715-96634728
36	CTCF	chr7:96635640-96635790	HepG2	liver:	n/a	n/a
37	CTCF	chr7:96634743-96634819	NHEK	skin:	n/a	n/a
38	CTCF	chr7:96634706-96634837	H1-hESC	embryonic stem cell:	n/a	chr7:96634715-96634728
39	CTCF	chr7:96635515-96635741	H1-hESC	embryonic stem cell:	n/a	n/a
40	CTCF	chr7:96635600-96635750	WERI-Rb-1	eye:	n/a	n/a
41	CTCF	chr7:96635577-96635730	SK-N-SH_RA	brain:	n/a	n/a
42	CTCF	chr7:96635660-96635810	SK-N-SH_RA	brain:	n/a	n/a
43	CTCF	chr7:96634720-96634870	HMEC	breast:	n/a	n/a
44	CTCF	chr7:96635460-96635610	SK-N-SH_RA	brain:	n/a	n/a
45	CTCF	chr7:96634680-96634830	SK-N-SH_RA	brain:	n/a	chr7:96634715-96634728
46	CTCF	chr7:96635634-96635738	NHEK	skin:	n/a	n/a
47	CTCF	chr7:96634700-96634850	HEK293	kidney:	n/a	chr7:96634715-96634728
48	CTCF	chr7:96634640-96634790	Caco-2	colon:	n/a	chr7:96634715-96634728
49	CTCF	chr7:96634740-96634890	WERI-Rb-1	eye:	n/a	n/a
50	CTCF	chr7:96636620-96636770	WERI-Rb-1	eye:	n/a	n/a

(count:793 , 50 per page) page: 1 2 3 4 5 6 7 ... 16

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr7:96634763-96634813	Hela-S3	cervix:	n/a
2	chr7:96636116-96636166	AG10803	skin:	n/a
3	chr7:96635624-96635674	AG04450	lung:	fetal
4	chr7:96634623-96634673	HEEpiC	esophagus:	n/a
5	chr7:96634763-96634813	U87	brain:	n/a
6	chr7:96634480-96634530	BJ	skin:	n/a
7	chr7:96634914-96634964	HL-60	blood:	n/a
8	chr7:96634914-96634964	ProgFib	skin:	n/a
9	chr7:96635336-96635386	PrEC	prostate:	n/a
10	chr7:96635336-96635386	HRE	kidney:	n/a
11	chr7:96636116-96636166	SAEC	small airway:	n/a
12	chr7:96634480-96634530	T-47D	breast:	n/a
13	chr7:96636192-96636242	GM12891	blood:	n/a
14	chr7:96636116-96636166	HEEpiC	esophagus:	n/a
15	chr7:96636116-96636166	AG04450	lung:	fetal
16	chr7:96634914-96634964	SAEC	small airway:	n/a
17	chr7:96635336-96635386	Hepatocyte	liver:	n/a
18	chr7:96634660-96634710	HCF	heart:	n/a
19	chr7:96635868-96635918	AG04450	lung:	fetal
20	chr7:96634660-96634710	BE2_C	brain:	n/a
21	chr7:96635336-96635386	GM19239	blood:	n/a
22	chr7:96635525-96635575	ovcar-3	ovarian:	n/a
23	chr7:96634660-96634710	AG09309	skin:	n/a
24	chr7:96634763-96634813	HNPCEpiC	eye:	n/a
25	chr7:96635748-96635798	HUVEC	blood vessel:	n/a
26	chr7:96634623-96634673	GM06990	blood:	n/a
27	chr7:96634623-96634673	Hela-S3	cervix:	n/a
28	chr7:96634914-96634964	HMEC	breast:	n/a
29	chr7:96635336-96635386	PANC-1	pancreas:	n/a
30	chr7:96634623-96634673	SK-N-SH_RA	brain:	n/a
31	chr7:96634763-96634813	PANC-1	pancreas:	n/a
32	chr7:96634914-96634964	HRPEpiC	eye:	n/a
33	chr7:96634480-96634530	SAEC	small airway:	n/a
34	chr7:96634914-96634964	LNCaP	prostate:	n/a
35	chr7:96635336-96635386	HPAEpiC	pulmonary alveolar:	n/a
36	chr7:96634623-96634673	A549	lung:	n/a
37	chr7:96635748-96635798	H1-hESC	embryonic stem cell:	embryo
38	chr7:96635868-96635918	HEEpiC	esophagus:	n/a
39	chr7:96634763-96634813	HL-60	blood:	n/a
40	chr7:96635868-96635918	HepG2	liver:	n/a
41	chr7:96636616-96636666	AG09309	skin:	n/a
42	chr7:96636192-96636242	ovcar-3	ovarian:	n/a
43	chr7:96634914-96634964	PrEC	prostate:	n/a
44	chr7:96634660-96634710	CMK	blood:	n/a
45	chr7:96635525-96635575	NT2-D1	testis:	n/a
46	chr7:96634623-96634673	HCF	heart:	n/a
47	chr7:96635336-96635386	K562	blood:	n/a
48	chr7:96634660-96634710	AoSMC	blood vessel:	n/a
49	chr7:96634660-96634710	HEK293	kidney:	embryo
50	chr7:96634763-96634813	HEEpiC	esophagus:	n/a

No data

Variant related genes	Relation type
DLX6	TF binding region
DLX6-AS1	TF binding region
DLX6	CpG island
DLX6-AS1	CpG island

Extended variants
information (count: 68 )
Associated
traits (count: 80 )

Variant overlapped rSNPs/rCNVs (count:68 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs575035612	chr7:96634456-96634457	Bivalent/Poised TSS Flanking Active TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers ZNF genes & repeats	TF binding region	2 gene(s)	Overlapped CNVs	n/a
2	rs540645357	chr7:96634468-96634469	Bivalent/Poised TSS Flanking Active TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers ZNF genes & repeats	TF binding region	2 gene(s)	Overlapped CNVs	n/a
3	rs376244226	chr7:96634494-96634495	Bivalent/Poised TSS Flanking Active TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers ZNF genes & repeats	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
4	rs187274514	chr7:96634579-96634580	Bivalent/Poised TSS Flanking Active TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers ZNF genes & repeats	TF binding region	2 gene(s)	Overlapped CNVs	n/a
5	rs1917937	chr7:96634633-96634634	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS ZNF genes & repeats	TF binding region CpG island	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
6	rs562751338	chr7:96634662-96634663	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS ZNF genes & repeats	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
7	rs142110811	chr7:96634669-96634670	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS ZNF genes & repeats	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
8	rs374280177	chr7:96634692-96634693	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS ZNF genes & repeats	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
9	rs561852848	chr7:96634714-96634715	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS ZNF genes & repeats	TF binding region	2 gene(s)	Overlapped CNVs	n/a
10	rs368757420	chr7:96634810-96634811	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers ZNF genes & repeats	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
11	rs547019388	chr7:96634853-96634854	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers ZNF genes & repeats	TF binding region	2 gene(s)	Overlapped CNVs	n/a
12	rs73404527	chr7:96634855-96634856	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers ZNF genes & repeats	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
13	rs539185736	chr7:96634860-96634861	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers ZNF genes & repeats	TF binding region	2 gene(s)	Overlapped CNVs	n/a
14	rs549606370	chr7:96634866-96634867	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers ZNF genes & repeats	TF binding region	2 gene(s)	Overlapped CNVs	n/a
15	rs373173113	chr7:96634922-96634923	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers ZNF genes & repeats	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
16	rs569684031	chr7:96634939-96634940	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers ZNF genes & repeats	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
17	rs538062442	chr7:96634981-96634982	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers ZNF genes & repeats	TF binding region	2 gene(s)	Overlapped CNVs	n/a
18	rs555109635	chr7:96634987-96634988	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Enhancers ZNF genes & repeats	TF binding region	2 gene(s)	Overlapped CNVs	n/a
19	rs568791222	chr7:96635017-96635018	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers ZNF genes & repeats	TF binding region	2 gene(s)	Overlapped CNVs	n/a
20	rs534471410	chr7:96635078-96635079	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers ZNF genes & repeats	TF binding region	2 gene(s)	Overlapped CNVs	n/a
21	rs554242056	chr7:96635093-96635094	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers ZNF genes & repeats	TF binding region	2 gene(s)	Overlapped CNVs	n/a
22	rs577308236	chr7:96635098-96635099	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers ZNF genes & repeats	TF binding region	2 gene(s)	Overlapped CNVs	n/a
23	rs546132655	chr7:96635141-96635142	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers ZNF genes & repeats	TF binding region	2 gene(s)	Overlapped CNVs	n/a
24	rs371484919	chr7:96635154-96635155	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers ZNF genes & repeats	TF binding region	2 gene(s)	Overlapped CNVs	n/a
25	rs569565671	chr7:96635192-96635193	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers ZNF genes & repeats	TF binding region	2 gene(s)	Overlapped CNVs	n/a
26	rs556392888	chr7:96635235-96635236	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers ZNF genes & repeats	TF binding region	2 gene(s)	Overlapped CNVs	n/a
27	rs375278814	chr7:96635281-96635282	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers ZNF genes & repeats	TF binding region	2 gene(s)	Overlapped CNVs	n/a
28	rs200317268	chr7:96635340-96635341	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers ZNF genes & repeats	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
29	rs530625473	chr7:96635363-96635364	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers ZNF genes & repeats	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
30	rs191859647	chr7:96635382-96635383	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers ZNF genes & repeats	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
31	rs35692573	chr7:96635388-96635389	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers ZNF genes & repeats	TF binding region	2 gene(s)	Overlapped CNVs	n/a
32	rs35478952	chr7:96635391-96635392	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers ZNF genes & repeats	TF binding region	2 gene(s)	Overlapped CNVs	n/a
33	rs541683065	chr7:96635399-96635400	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers ZNF genes & repeats	TF binding region	2 gene(s)	Overlapped CNVs	n/a
34	rs561901156	chr7:96635418-96635419	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
35	rs559903070	chr7:96635420-96635421	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
36	rs570498188	chr7:96635421-96635422	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
37	rs540915866	chr7:96635423-96635424	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
38	rs563784519	chr7:96635450-96635451	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
39	rs532765915	chr7:96635472-96635473	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
40	rs549707573	chr7:96635532-96635533	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
41	rs569667101	chr7:96635591-96635592	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
42	rs528954859	chr7:96635592-96635593	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
43	rs183079486	chr7:96635628-96635629	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
44	rs568654358	chr7:96635701-96635702	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
45	rs201763801	chr7:96635719-96635720	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
46	rs185935123	chr7:96635741-96635742	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
47	rs554510097	chr7:96635770-96635771	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
48	rs571118593	chr7:96635828-96635829	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
49	rs553337557	chr7:96635829-96635830	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
50	rs539466091	chr7:96635849-96635850	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:80)

Disease	PMID	Source
Basal cell lymphoma	17170743	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Thyroid cancer	19087340	CNVD
Seminomas	18059402	CNVD
Testicular cancer	18059402	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Autism	19415332	CNVD
Medulloblastoma	21979893	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
T-cell lymphomas	19863542	CNVD
Malaria	21533027	CNVD
Melanoma	18172304	CNVD
Renal cell carcinoma	19461508	CNVD
head and neck squamous cell carcinoma	19289630	CNVD
Stenocardia	21860640	CNVD
Vasospasm	21860640	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Ewing''s sarcoma	17952124	CNVD
Autism	22495311	CNVD
Wilms tumour	21544195	CNVD
Glioblastoma multiforme	21750150	CNVD
Cancer	21183584	CNVD
Hepatocellular carcinoma	16750200	CNVD
Non-small cell lung cancer	21829676	CNVD
Gastric cancer	24379144	CNVD
Glioblastoma multiforme	17002787	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Lissencephaly	21572526	CNVD
Breast cancer	17603634	CNVD
Liposarcoma	21253554	CNVD
Breast cancer	16397240	CNVD
Acute myeloid leukemia	16864856	CNVD
Squamous cell cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Glioblastoma multiforme	17387387	CNVD
Low-grade fibromyxoid sarcoma	0	CNVD
Oligodendroglial tumors	17285580	CNVD
Endometrial cancer	22040021	CNVD
Burkitt''s lymphoma	18698080	CNVD
Breast cancer	21264507	CNVD
Shwachman-Diamond syndrome	22934832	CNVD
Colorectal cancer	19359472	CNVD
Cutaneous malignant melanoma	17690212	CNVD
Leukemia	17361228	CNVD
Breast cancer	16461572	CNVD
Peripheral t-cell lymphoma	19118030	CNVD
Malignant melanoma	17690212	CNVD
Renal cell carcinoma	18592004	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Multiple myeloma	17550852	CNVD
small cell lung cancer	20016488	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Neurodevelopmental disorder	22521361	CNVD
Metanephric adenoma	20802469	CNVD
abortions and stillbirths	19751515	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Acute myeloid leukemia	20729466	CNVD
Lung cancer	18438408	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Schizophrenia	17879154	CNVD
Prostate cancer	16573809	CNVD
Prostate cancer	16461572	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Autism	20858243	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Burkitt''s lymphoma	19759907	CNVD
Malignant melanoma	17260012	CNVD
Myoclonus-dystonia	17898012	CNVD
Myelodysplastic syndrome	21251322	CNVD
Cancer	20164920	CNVD
abnormal development	18461090	CNVD
Acute myeloid leukemia	21251322	CNVD
Breast cancer	21785460	CNVD
Myelofibrosis	22110671	CNVD
Cancer	20164919	CNVD
Breast cancer	22522925	CNVD
Prostate cancer	22341455	CNVD

Chromatin state (count:413 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr7:96625000-96644000	Bivalent/Poised TSS	Fetal Brain Female	brain
2	chr7:96627400-96634800	Bivalent/Poised TSS	Ganglion Eminence derived primary cultured neurospheres	brain
3	chr7:96628000-96643200	Bivalent/Poised TSS	Brain Germinal Matrix	brain
4	chr7:96633000-96634600	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin03	Skin
5	chr7:96633000-96634800	Bivalent Enhancer	Primary Natural Killer cells fromperipheralblood	blood
6	chr7:96633000-96635000	Bivalent Enhancer	Primary T helper memory cells from peripheral blood 1	blood
7	chr7:96633600-96634600	Bivalent Enhancer	Primary T killer memory cells from peripheral blood	blood
8	chr7:96633800-96634600	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
9	chr7:96633800-96637000	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
10	chr7:96634000-96634600	Flanking Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
11	chr7:96634000-96634600	Bivalent Enhancer	Rectal Mucosa Donor 31	rectum
12	chr7:96634000-96638200	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
13	chr7:96634200-96634600	Bivalent Enhancer	Esophagus	oesophagus
14	chr7:96634200-96634600	Flanking Bivalent TSS/Enh	Placenta	Placenta
15	chr7:96634200-96634600	Enhancers	Ovary	ovary
16	chr7:96634200-96634600	Flanking Active TSS	Osteobl	bone
17	chr7:96634200-96634800	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
18	chr7:96634200-96634800	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
19	chr7:96634200-96634800	Bivalent Enhancer	Primary T killer naive cells fromperipheralblood	blood
20	chr7:96634200-96634800	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
21	chr7:96634200-96634800	Bivalent Enhancer	Fetal Brain Male	brain
22	chr7:96634200-96634800	Bivalent Enhancer	Fetal Muscle Leg	muscle
23	chr7:96634200-96634800	Bivalent/Poised TSS	A549	lung
24	chr7:96634200-96635000	Flanking Bivalent TSS/Enh	Primary T helper 17 cells PMA-I stimulated	--
25	chr7:96634200-96635000	Flanking Bivalent TSS/Enh	Foreskin Keratinocyte Primary Cells skin03	Skin
26	chr7:96634200-96635200	Bivalent Enhancer	Primary B cells from peripheral blood	blood
27	chr7:96634200-96635200	Bivalent Enhancer	Lung	lung
28	chr7:96634200-96635800	Bivalent/Poised TSS	HSMM	muscle
29	chr7:96634200-96636000	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell
30	chr7:96634200-96636000	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
31	chr7:96634400-96634600	Flanking Active TSS	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
32	chr7:96634400-96634600	Bivalent Enhancer	H1 Derived Mesenchymal Stem Cells	ES cell derived
33	chr7:96634400-96634600	Bivalent Enhancer	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
34	chr7:96634400-96634600	Bivalent/Poised TSS	H9 Cell Line	embryonic stem cell
35	chr7:96634400-96634600	Bivalent Enhancer	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
36	chr7:96634400-96634600	Bivalent Enhancer	H9 Derived Neuron Cultured Cells	ES cell derived
37	chr7:96634400-96634600	Flanking Bivalent TSS/Enh	iPS-18 Cell Line	embryonic stem cell
38	chr7:96634400-96634600	Bivalent/Poised TSS	iPS DF 19.11 Cell Line	embryonic stem cell
39	chr7:96634400-96634600	Bivalent/Poised TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
40	chr7:96634400-96634600	Flanking Active TSS	ES-UCSF4 Cell Line	embryonic stem cell
41	chr7:96634400-96634600	Bivalent Enhancer	Muscle Satellite Cultured Cells	--
42	chr7:96634400-96634600	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin01	Skin
43	chr7:96634400-96634600	Bivalent/Poised TSS	Brain Hippocampus Middle	brain
44	chr7:96634400-96634600	Bivalent/Poised TSS	Duodenum Mucosa	Duodenum
45	chr7:96634400-96634600	Bivalent Enhancer	Fetal Intestine Large	intestine
46	chr7:96634400-96634600	Bivalent Enhancer	Rectal Mucosa Donor 29	rectum
47	chr7:96634400-96634600	Bivalent Enhancer	Rectal Smooth Muscle	rectum
48	chr7:96634400-96634600	Bivalent Enhancer	Skeletal Muscle Female	skeletal muscle
49	chr7:96634400-96634600	Flanking Bivalent TSS/Enh	HUVEC	blood vessel
50	chr7:96634400-96634600	Bivalent Enhancer	NHDF-Ad	bronchial

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links